Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
    • Sussex-wide protocols
    • Brighton & Hove protocols
    • East Sussex protocols
    • West Sussex protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • 2026
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
    • Sussex-wide protocols
    • Brighton & Hove protocols
      • Azathioprine / mercaptopurine (+/- allopurinol)
      • Azathioprine
      • Azathioprine [Sussex MSK Partnership central patients only]
      • Chlorothiazide
      • Ciclosporin [Sussex MSK Partnership central patients only]
      • Cinacalcet – December 2019
      • Denosumab in bony metastases
      • Diazoxide
      • Ikervis
      • Leflunomide – Sussex MSK Partnership [central patients only]
      • Methotrexate – Sussex MSK Partnership [central patients only]
      • Mycophenolate [Sussex MSK Partnership central patients only]
      • Nebulised Tobramycin
      • Perampanel
      • Sulfasalazine
      • Sulfasalazine [Sussex MSK Partnership central patients only]
      • Sustanon (children)
      • Testosterone Enantate (children)
    • East Sussex protocols
    • West Sussex protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Shared care protocol

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026